高级检索
当前位置: 首页 > 详情页

A polymorphism at the miR-502 binding site in the 3 '-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Gastroenterology and Hepatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China [2]Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China [3]Department of Gynaecology Ultrasound, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China [4]Hebei Key Lab of Laboratory Animal Science, Hebei Medical University, Shijiazhuang, People’s Republic of China [5]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China
出处:
ISSN:

关键词: HCC SET8 microRNA outcome polymorphism

摘要:
MicroRNAs (miRNAs) can bind to the 3'-untranslated regions (UTRs) of messenger RNAs, where they interfere with translation and thereby regulate cell differentiation, apoptosis and tumorigenesis. Genetic polymorphisms in the 3'-UTRs targeted by miRNAs alter the strength of miRNA binding in a manner that affects the behavior of individual miRNAs. The histone methyltransferase SET8 has been reported to methylate TP53 and regulate genomic stability. We analyzed a single-nucleotide polymorphism (rs16917496) within the miR-502 miRNA seed region for the 3'-UTR of SET8 in Chinese patients with hepatocellular carcinoma (HCC). The SET8 CC genotype was independently associated with longer postoperative survival in patients with HCC by multivariate analysis (relative risk, 0.175; 95% CI = 0.0530.577; p = 0.004). The SET8 CC genotype was associated with reduced SET8 protein levels based on the immunostaining of 51 HCC tissue samples. We also found that the low SET8 levels were associated with longer HCC survival. Our data suggest that SET8 modifies HCC outcome by altering its expression, which depends, at least in part, on its binding affinity with miR-502. The analysis of genetic polymorphisms in miRNA binding sites can help to identify patient subgroups that are at high risk for poor disease outcomes.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2012]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2012]版:
Q1 ONCOLOGY
最新[2024]版:
Q1 ONCOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Department of Gastroenterology and Hepatology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构: [5]Research Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China [*1]Research Center,The Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang 050011, People’s Republic of China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42317 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号